718 related articles for article (PubMed ID: 15585882)
1. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.
Re F; Strominger JL
J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882
[TBL] [Abstract][Full Text] [Related]
2. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.
Parker LC; Whyte MK; Vogel SN; Dower SK; Sabroe I
J Immunol; 2004 Apr; 172(8):4977-86. PubMed ID: 15067079
[TBL] [Abstract][Full Text] [Related]
5. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.
Napolitani G; Rinaldi A; Bertoni F; Sallusto F; Lanzavecchia A
Nat Immunol; 2005 Aug; 6(8):769-76. PubMed ID: 15995707
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.
Agrawal S; Agrawal A; Doughty B; Gerwitz A; Blenis J; Van Dyke T; Pulendran B
J Immunol; 2003 Nov; 171(10):4984-9. PubMed ID: 14607893
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of Toll-like receptors in chicken heterophils.
Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
9. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
[TBL] [Abstract][Full Text] [Related]
10. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
Sirén J; Pirhonen J; Julkunen I; Matikainen S
J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
Salvi V; Scutera S; Rossi S; Zucca M; Alessandria M; Greco D; Bosisio D; Sozzani S; Musso T
J Leukoc Biol; 2013 Jul; 94(1):147-58. PubMed ID: 23610145
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
[TBL] [Abstract][Full Text] [Related]
15. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
[TBL] [Abstract][Full Text] [Related]
16. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
17. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.
Means TK; Hayashi F; Smith KD; Aderem A; Luster AD
J Immunol; 2003 May; 170(10):5165-75. PubMed ID: 12734364
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
Netea MG; Ferwerda G; de Jong DJ; Jansen T; Jacobs L; Kramer M; Naber TH; Drenth JP; Girardin SE; Kullberg BJ; Adema GJ; Van der Meer JW
J Immunol; 2005 May; 174(10):6518-23. PubMed ID: 15879155
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.
Muzio M; Bosisio D; Polentarutti N; D'amico G; Stoppacciaro A; Mancinelli R; van't Veer C; Penton-Rol G; Ruco LP; Allavena P; Mantovani A
J Immunol; 2000 Jun; 164(11):5998-6004. PubMed ID: 10820283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
